A detailed history of Pds Planning, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pds Planning, Inc holds 5,514 shares of BMY stock, worth $317,882. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,514
Previous 4,815 14.52%
Holding current value
$317,882
Previous $199,000 43.22%
% of portfolio
0.03%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$39.66 - $51.75 $27,722 - $36,173
699 Added 14.52%
5,514 $285,000
Q2 2024

Aug 07, 2024

SELL
$40.25 - $52.99 $100,142 - $131,839
-2,488 Reduced 34.07%
4,815 $199,000
Q1 2024

May 01, 2024

BUY
$47.98 - $54.4 $35,649 - $40,419
743 Added 11.33%
7,303 $396,000
Q4 2023

Feb 01, 2024

SELL
$48.48 - $57.85 $80,428 - $95,973
-1,659 Reduced 20.18%
6,560 $336,000
Q3 2023

Oct 20, 2023

BUY
$57.89 - $64.73 $32,592 - $36,442
563 Added 7.35%
8,219 $477,000
Q2 2023

Jul 20, 2023

BUY
$63.71 - $70.74 $24,273 - $26,951
381 Added 5.24%
7,656 $489,000
Q1 2023

May 01, 2023

BUY
$65.71 - $74.53 $88,511 - $100,391
1,347 Added 22.72%
7,275 $504,000
Q4 2022

Jan 26, 2023

BUY
$68.48 - $81.09 $5,272 - $6,243
77 Added 1.32%
5,928 $0
Q3 2022

Nov 02, 2022

BUY
$0.13 - $76.84 $47 - $28,277
368 Added 6.71%
5,851 $416,000
Q2 2022

Jul 15, 2022

BUY
$72.62 - $79.98 $46,476 - $51,187
640 Added 13.21%
5,483 $422,000
Q1 2022

Apr 18, 2022

BUY
$61.48 - $73.72 $42,974 - $51,530
699 Added 16.87%
4,843 $354,000
Q4 2021

Jan 25, 2022

SELL
$53.63 - $62.52 $55,828 - $65,083
-1,041 Reduced 20.08%
4,144 $258,000
Q3 2021

Oct 22, 2021

BUY
$59.17 - $69.31 $39,348 - $46,091
665 Added 14.71%
5,185 $307,000
Q2 2021

Jul 26, 2021

BUY
$61.91 - $67.42 $53,304 - $58,048
861 Added 23.53%
4,520 $302,000
Q1 2021

Apr 20, 2021

BUY
$59.34 - $66.74 $2,848 - $3,203
48 Added 1.33%
3,659 $231,000
Q4 2020

Jan 21, 2021

BUY
$57.74 - $65.43 $208,499 - $236,267
3,611 New
3,611 $224,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pds Planning, Inc Portfolio

Follow Pds Planning, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pds Planning, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pds Planning, Inc with notifications on news.